Company Information

CIN
Status
Date of Incorporation
25 January 1999
State / ROC
/ ROC Delhi
Last Balance Sheet
31 March 2023
Last Annual Meeting
Paid Up Capital
23,458,580
Authorised Capital
50,000,000

Directors

Abhishek Anand
Abhishek Anand
Director/Designated Partner
over 2 years ago
Sanjay Khatau Asher
Sanjay Khatau Asher
Director/Designated Partner
almost 3 years ago
Deepak Sood
Deepak Sood
Director/Designated Partner
over 4 years ago

Past Directors

Vivek Vasant Save
Vivek Vasant Save
Managing Director
almost 14 years ago
Hargovind Rathore
Hargovind Rathore
Managing Director
over 17 years ago

Patents

Process For The Preparation Of Enolate Salts Of 4 Fluoro 2 Hydroxymethylene 3 Oxo Butyrates

Enolate salts of 4 fluoro 2 hydroxymethylene 3 oxobutyrates of formula wherein R is C alkyl R and R are independently hydrogen or fluorine M is an alkali or alkaline earth metal and n is 1 or 2 are prepared from enolate salts of the corresponding 4 fluoro 3 oxobutyrates and carbon monoxide. The enolate salts of form...

"Process For The Preparation Of (1 S, 4 R) 2 Oxa 3 Azabicyclo[2,2.1]Hept 5 Enes"

Enantiomerically enriched (1 S,4R)-2-oxa-3-azabicyclo[2.2.1]hept-5-ene of formula wherein PG1 is an amino-protective group, are prepared from cyclopentadiene via hetero-Diels-Alder cycloaddition with protected 1-C-nitroso-P-D-ribofuranosyl halides of formula wherein X is a halogen atom selected from fluorine, chlori...

A Process For The Production Of Carnitine From ß Lactones

The invention relates to a method for the production of L carnitine wherein a ß lactone which is a 4 (halomethyl)oxetane 2 one is converted into carnitine with trimethylamme (TMA) wherein the ß lactone is not subjected to a basic hydrolysis step before being contacted with the trimethylamme. The invention also relat...

A Process For The Production Of Carnitine

The invention relates to a method for the production of L carnitine wherein a chiral ß lactone carnitine precursor is obtained by a [2+2] cycloaddition of ketene with an aldehyde X CH CHO wherein X is selected from CI Br I and trimethylamine in the presence of a chiral catalyst.

Constitutive Promoter

The invention relates to an isolated nucleic acid sequence comprising a promoter, which is a native sequence of Pichia pastoris comprising the nucleic acid sequence of pCSl of SEQ ID 1, or a functionally active variant thereof which is a size variant, a mutant or hybrid of SEQ ID 1, or a combination thereof, express...

Novel Tricyanoborates

The present invention relates to novel tricyanoborates of the general formula Catn+ [B(CN)3(XR1)]-n, wherein R1 is C1-6 alkyl, C2-6 alkenyl, C6-10 aryl or benzyl; X is oxygen or sulfur; and Catn+ is a cation with n being 1 or 2, which is selected from the group consisting of an inorganic cation and an organic cation...

Method For Preparation Of 4 Alkoxy L,L,L Trifluorobut 3 En 2 Ones From 1,1,1 Trifluoro Acetone

The invention discloses a method for the preparation of 4-alkoxy- 1,1,1 -trifluorobut-3-en-2-ones from 1,1,1 -trifluoro - acetone.

Process For Preparing Cyanoacetic Esters

The present invention relates to a process for preparing cyanoacetic ester of the general formula: in which R is C1-10-alkyl, C3-10-alkenyl or ary-C1-4-alkyl, characterized in that an alkali metal cyanoacetate is reacted in an aqueous/organic two-phase system in the presence of a phase-transfer catalyst with...

Method For Preparation Of Bis(fluorosulfonyl) Imide

The invention relates to a method for the preparation of bis(fluorosulfonyl) imide and its derivatives at elevated temperature.

Method For The Preparation Of Bis (Fluorosulfonyl) Imide And Of Its Salts

The invention relates to a method for the preparation of bis(fluorosulfonyl)-imide, the method starts from bis(chlorosulfonyl)-imide or its respective derivatives, which is reacted with HF in the presence of chlorosulfonyl isocyanate, and uses a certain extraction step for extraction of bis(fluorosulfonyl)-imide fro...

Registered Trademarks

Gs Gene Expression System Lonza

[Class : 42] Scientific And Medical Research; Technical Consultancy And Project Planning In The Field Of Proteins; Research And Development In The Field Of Proteins For Others.

Gs Gene Expression System Lonza

[Class : 40] Manufacturing For Others, Of Genetically Modified Cells And Vectors For Production Of Human, Animal And Synthetic Proteins, For Use In Scientific Research, In Pharmaceutical Research And For Clinical And Commercial Use, As Well As For Clinical And Commercial Use In Human And Animal Therapies.

Gs Gene Expression System Lonza

[Class : 5] Biological Preparations, Namely Genetically Modified Cells And Genetically Modified Vectors For Production Of Human, Animal And Synthetic Proteins, For Clinical And Commercial Use In Human And Animal Therapies.
View +23 more Brands for Lonza India Private Limited.